Xu, Xin <br/><br/>
Doxycycline improves clinical outcomes during cystic fibrosis exacerbations.  [electronic resource] 

 -  The European respiratory journal  04 2017 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1399-3003 
<br/><br/><label>Standard No.: </label>10.1183/13993003.01102-2016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Alabama<br/>Cystic Fibrosis--drug therapy<br/>Double-Blind Method<br/>Doxycycline--therapeutic use<br/>Female<br/>Forced Expiratory Volume<br/>Humans<br/>Kaplan-Meier Estimate<br/>Linear Models<br/>Lung--physiopathology<br/>Male<br/>Matrix Metalloproteinase 9--metabolism<br/>Sputum--chemistry<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Young Adult